DE69705877T2 - Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie - Google Patents

Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie

Info

Publication number
DE69705877T2
DE69705877T2 DE69705877T DE69705877T DE69705877T2 DE 69705877 T2 DE69705877 T2 DE 69705877T2 DE 69705877 T DE69705877 T DE 69705877T DE 69705877 T DE69705877 T DE 69705877T DE 69705877 T2 DE69705877 T2 DE 69705877T2
Authority
DE
Germany
Prior art keywords
hyperphosphatemia
medicament
manufacture
treatment
anion exchange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705877T
Other languages
English (en)
Other versions
DE69705877D1 (de
Inventor
Masayuki Matsuka
Hiroshi Shimada
Mizue Kawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of DE69705877D1 publication Critical patent/DE69705877D1/de
Publication of DE69705877T2 publication Critical patent/DE69705877T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69705877T 1996-03-05 1997-03-04 Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie Expired - Lifetime DE69705877T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4776596 1996-03-05

Publications (2)

Publication Number Publication Date
DE69705877D1 DE69705877D1 (de) 2001-09-06
DE69705877T2 true DE69705877T2 (de) 2002-06-06

Family

ID=12784473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705877T Expired - Lifetime DE69705877T2 (de) 1996-03-05 1997-03-04 Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie

Country Status (8)

Country Link
US (1) US5980881A (de)
EP (1) EP0793960B1 (de)
KR (1) KR100561784B1 (de)
CN (1) CN1080121C (de)
CA (1) CA2199194C (de)
DE (1) DE69705877T2 (de)
ES (1) ES2162658T3 (de)
TW (1) TW528597B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1230118A (zh) * 1996-07-19 1999-09-29 日研化学株式会社 高磷血症治疗剂
US6726905B1 (en) * 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
WO2001066606A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci
WO2001066607A1 (fr) * 2000-03-09 2001-09-13 Hisamitsu Pharmaceutical Co., Inc. Resine echangeuse d'anions reticulee ou sel de celle-ci et adsorbant phosphoreux la contenant
AU2001241095A1 (en) * 2000-03-13 2001-09-24 Hisamitsu Pharmaceutical Co. Inc. Preventives and/or remedies for hyperphosphatemia
ATE473007T1 (de) * 2000-11-28 2010-07-15 Mitsubishi Tanabe Pharma Corp Exkretionsbeschleuniger für eine akkumulative chlorverbindung
JPWO2002043761A1 (ja) * 2000-11-28 2004-04-02 三菱ウェルファーマ株式会社 抗肥満剤及び健康食品
CN1270724C (zh) 2001-07-30 2006-08-23 三菱制药株式会社 餐后高血糖改善剂
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
EP3574896A1 (de) 2004-03-30 2019-12-04 Relypsa, Inc. Ionenbindende polymere und verwendungen davon
ITME20040015A1 (it) * 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.
US20070172472A1 (en) * 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
WO2007089578A2 (en) * 2006-01-30 2007-08-09 Globoasia, Llc Method for selecting phosphate binder and its uses thereof
JP5147695B2 (ja) 2006-06-16 2013-02-20 田辺三菱製薬株式会社 糸球体疾患の予防及び／または治療剤
JP5301273B2 (ja) * 2006-08-09 2013-09-25 田辺三菱製薬株式会社 錠剤
ES2573636T3 (es) * 2006-10-25 2016-06-09 Wisconsin Alumni Research Foundation Métodos para reducir la absorción de fosfato empleando un anticuerpo anti-Npt2B
BRPI0716317A8 (pt) * 2006-10-26 2019-02-05 Aovatechnologies Inc método para reduzir a absorção de fosfato em um indivíduo animal humano ou não-humano e método para reduzir a absorção de fosfato em um indivíduo humano
JP5487379B2 (ja) * 2008-03-19 2014-05-07 森下仁丹株式会社 血中リン濃度上昇抑制剤
CN104258829B (zh) * 2014-09-24 2016-08-31 珠海健帆生物科技股份有限公司 血磷吸附剂及其制备方法、用于血液灌流的吸附柱
CN106366311B (zh) * 2015-07-23 2019-08-13 山东诚创医药技术开发有限公司 一种考来替兰的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150017A (en) * 1980-04-22 1981-11-20 Mitsubishi Petrochem Co Ltd Cholesteril lowering agent
JPS57142920A (en) * 1981-03-02 1982-09-03 Mitsubishi Petrochem Co Ltd Cholesterol depressant
DE3272059D1 (en) * 1982-01-18 1986-08-28 Mitsubishi Petrochemical Co Cholesterol lowering drug
JPS60209523A (ja) * 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
AU6818894A (en) * 1993-05-20 1994-12-20 Geltex Pharmaceuticals, Inc. Process for adjusting ion concentration in a patient and compositions therefor
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
WO1996021454A1 (en) * 1995-01-12 1996-07-18 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration

Also Published As

Publication number Publication date
TW528597B (en) 2003-04-21
CN1080121C (zh) 2002-03-06
KR100561784B1 (ko) 2006-06-21
CN1169285A (zh) 1998-01-07
DE69705877D1 (de) 2001-09-06
EP0793960A1 (de) 1997-09-10
CA2199194A1 (en) 1997-09-05
EP0793960B1 (de) 2001-08-01
US5980881A (en) 1999-11-09
CA2199194C (en) 2005-12-27
KR970064610A (ko) 1997-10-13
ES2162658T3 (es) 2002-01-01

Similar Documents

Publication Publication Date Title
DE69705877T2 (de) Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
DE69534002D1 (de) Verwendung von Phosphatidylserinen zur Herstellung eines Arzneimittels zur Verbesserung der Gehirntätigkeit
DE69736183D1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
DE59501599D1 (de) Verfahren zur Herstellung von Propandiol-1,2
DE69435330D1 (de) Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen
ATE248599T1 (de) Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
DE69310065D1 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
DE69022249T2 (de) Knochenwachsapplikator zur Behandlung von Knochengewebe.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69109560T2 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE69010251T2 (de) Dentale Einheit zur Behandlung eines Wurzelkanals.
DE69522399D1 (de) Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen
DE3785740T2 (de) Verwendung von Carboxamid-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung der Hyperlipämie.
DE69233725D1 (de) Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
DE69910202D1 (de) EGR-1 zur Herstellung eines Medikamentes zur Behandlung von Wunden
DE69513110T2 (de) Verfahren zur Herstellung von exotherm reagierenden Zusammensetzungen
DE59200799D1 (de) Verfahren zur Herstellung von mehrkernigen aromatischen Polyaminen.
DE59200828D1 (de) Verfahren zur Herstellung von mehrkernigen aromatischen Polyaminen.
DE69423577T2 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
DE69313261D1 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69738320D1 (de) Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch
DE59501060D1 (de) Verfahren zur Herstellung von 2,5-Dihydrofuran
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69300037T2 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.